Doctors at KIMS Hospitals, Kondapur, have performed a rare and highly complex laparoscopic Whipple procedure on a 52-year-old woman who had previously undergone open pancreatic surgery, marking a ...

"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.

A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday. Researchers say the findings ...

A new drug that targets a gene behind pancreatic cancer has physicians and researchers cautiously optimistic about improved treatment for one of the deadliest cancers. Researchers found that a new ...

A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer. The drug, called daraxonrasib, appears to be a ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. This undated microscope image from USC via the NIH ...

WASHINGTON — A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of ...

At last week's meeting of top cancer researchers, there was big news. It's a new drug that researchers say is redefining treatment of pancreatic cancer, a disease once thought to be virtually ...

CHICAGO, May 31 (Reuters) - Revolution Medicine's (RVMD.O), opens new tab experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some ...

Every single patient with advanced pancreatic cancer who walked into Dr. Zev Wainberg’s office told him they would rather take an experimental medication than endure another round of chemotherapy.

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...